IP Library Granted Patent US 11,065,204
Granted Patent B2
US 11,065,204 · App. 16/540,426 · Granted Jul 20, 2021

Oxidized cellulose microspheres

Inventors: Phillip Blaskovich (Salem, MA); Rachit Ohri (Framingham, MA); Lan Pham (Nashua, NH)
Assignee: Covidien LP
A61K9/1682A61K9/1652A61K9/1694A61K31/445A61K31/714A61K33/24A61L15/28A61L27/20B01J13/12B01J13/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,065,204
App. No.
16/540,426
Granted
Jul 20, 2021
Kind
B2
Abstract

A process for forming microspheres is disclosed. The process includes contacting a solvent with a modified cellulose to form a solution; contacting the modified cellulose solution with at least one bioactive agent to form a discontinuous phase liquid; contacting the discontinuous phase liquid with a continuous phase liquid to form an emulsion; and contacting the emulsion with a third phase liquid to extract the solvent from the emulsion, thereby forming a plurality of modified cellulose microspheres.

Claims (18)

1. A composition comprising:

a first microsphere including a biodegradable polymer; and

at least one second microsphere encapsulated in the first microsphere, wherein the at least one second microsphere includes an oxidized cellulose and at least one bioactive agent.

2. The composition according to claim 1 , further comprising:

at least one third microsphere encapsulated in the second microsphere, the at least one third microsphere including the biodegradable polymer.

3. The composition according to claim 2 , wherein the biodegradable polymer is an aliphatic polyester.

4. The composition according to claim 3 , wherein the aliphatic polyester is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof.

5. The composition according to claim 1 , further comprising at least one additional bioactive agent.

6. The composition according to claim 5 , wherein the at least one additional bioactive agent is selected from the group consisting of a hydrophilic bioactive agent, a protein therapeutic, a biologic, and combinations thereof.

7. A composition comprising:

a plurality of first microspheres formed from a biodegradable polymer; and

a plurality of second microspheres encapsulated in at least a portion of the plurality of first microspheres, wherein the plurality of second microspheres are formed from an oxidized cellulose and include at least one bioactive agent.

8. The composition according to claim 7 , further comprising:

a plurality of third microsphere encapsulated in at least a portion of the plurality of second microspheres, wherein the plurality of second microspheres are formed from the biodegradable polymer.

9. The composition according to claim 8 , wherein the biodegradable polymer is an aliphatic polyester.

10. The composition according to claim 9 , wherein the aliphatic polyester is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof.

11. The composition according to claim 7 , further comprising at least one additional bioactive agent.

12. The composition according to claim 11 , wherein the at least one additional bioactive agent is selected from the group consisting of a hydrophilic bioactive agent, a protein therapeutic, a biologic, and combinations thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2019
From: BLASKOVICH, PHILLIP; OHRI, RACHIT
To: CONFLUENT SURGICAL, INC.
Reel/Frame 050459/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2019
From: CONFLUENT SURGICAL, INC.
To: COVIDIEN LP
Reel/Frame 050459/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2019
From: PHAM, LAN
To: COVIDIEN LP
Reel/Frame 050459/0511 →